50
Participants
Start Date
July 1, 2022
Primary Completion Date
July 1, 2025
Study Completion Date
December 30, 2025
Regorafenib
Regorafenib:120mg/d，Po，qd,d1-d21，Every 4 weeks
Raltitrexed
Raltitrexed:3mg/㎡，ivgtt，d1，Every 3 weeks
The People's Hospital of Liaoning Province
OTHER
Anshan Tumor Hospital
OTHER
The First Affiliated Hospital of Dalian Medical University
OTHER
The Second Affiliated Hospital of Dalian Medical University
OTHER
Benxi Cental Hospital
OTHER
China Medical University, China
OTHER